Clinical Trial Update: Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques [Phase 1]

View source ↗

Summary

Clinical trial update for a Phase 1 study of SFA002 in mild to moderate psoriasis plaques; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• SFA002

Snippet

Sponsor: SFA Therapeutics | Conditions: Psoriasis | Phase 1 | Status: RECRUITING